— News By Type —
Video Updates


Senate Bill 5536, the Blake decision bill on controlled substances, passed the House floor on an 83-13 vote and was signed into law. In this video, Rep. Peter Abbarno, R-Centralia, explains...

May 16, 2023

Rep. Peter Abbarno, R-Centralia, spoke in favor of a new version of Senate Bill 5536, a measure to criminalize possession of controlled substances.

May 16, 2023

Rep. Peter Abbarno, R-Centralia, appeared on Newsmax TV to discuss a trio of anti-firearm measures signed into law by Governor Inslee. “Governor Inslee is pretty famous for his incendiary rhetoric. [House...

April 28, 2023

Senate Bill 5536, the Blake decision bill on controlled substances, failed to pass off the House floor on a 43-55 vote. In this video, Rep. Peter Abbarno, R-Centralia, explains why House...

April 24, 2023

Rep. Peter Abbarno, R-Centralia, rose in opposition to Senate Bill 5536, a measure that would have created opportunities for drug law violators to game the system without punishment or undergoing treatment....

April 24, 2023

On April 12th, Rep. Peter Abbarno, R-Centralia, stood on the House floor and urged the body to vote no on Senate Bill 5599. The measure would allow youth shelters, and other...

April 20, 2023

The state House debated and voted on Senate Bill 5599 on April 12, 2023. From the House gallery, following the debate, assistant floor leaders Chris Corry and Peter Abbarno discussed the...

April 14, 2023

Rep. Peter Abbarno, R-Centralia, explained why House Republicans opposed Senate Bill 5082 – a measure abolishing advisory votes.

April 7, 2023

Rep. Peter Abbarno, R-Centralia, stood in opposition to Senate Bill 5082, which would eliminate the ability of Washingtonians to participate in advisory votes. Advisory votes were established under Initiative 960 in...

April 7, 2023

Rep. Peter Abbarno, R-Centralia, proposed amendment 545 to the operating budget, which would have eliminated the unpopular and unfair long-term care payroll tax. The amendment failed along partisan lines.

April 3, 2023